Ben Pockros
@BenPockros
Followers
661
Following
1K
Media
97
Statuses
287
PGY-4 @UMichUrology | MD/MBA @TuftsMedSchool
Joined April 2021
@BenPockros delivered a ⭐️stellar⭐️ talk today at #NCSAUA25 on the importance of residents in advocacy. So many ways to get involved - every voice counts! 💯@AmerUrological @UMUroResidency
0
1
1
Scary AI image… but so true Thanks for organizing a great session @kvnkoo
Residents, now is the best time to get started in advocacy for our specialty! @BenPockros shows through experience how impactful resident advocacy can be. Show up, come to #AUASummit26, give to #AUAPAC, and use your voice! #NCSAUA25
0
0
1
Residents, now is the best time to get started in advocacy for our specialty! @BenPockros shows through experience how impactful resident advocacy can be. Show up, come to #AUASummit26, give to #AUAPAC, and use your voice! #NCSAUA25
0
0
4
Powerful career reflections and advice by Dr. Stoffel #NCSAUA25 “The soup tastes better when stirred”
0
0
5
bpMRI currently offered at @UMichUrology for many patients on active surveillance. This study by @veerukasi @AlexBCDNg @AquaAsif could now open the door to bpMRI during the first diagnostic evaluation 🙌🏻
0
5
13
Grateful to help write this editorial with @wandering_gu @MattDavenportMD Kudos to the authors! The future is now for bpMRI! Cheaper, quicker, easier for patients ✅ Similar diagnostic accuracy ✅
Editorial: The PRIME trial establishes biparametric MRI as a viable alternative to multiparametric MRI for prostate cancer diagnosis, offering reduced time, cost, and invasiveness. https://t.co/MNravRRvhX
1
8
28
🚨Here we go🚨#PRIME trial in @JAMA_current today. Short biparametric MRI without contrast injection non-inferior to multiparametric MRI with contrast, c.sig PCa 29.2 vs 29.6%. n=555, 12 countries, 22 centres. Possible new standard for Pca diagnosis! 1/4
jamanetwork.com
This multinational prospective noninferiority trial assesses whether biparametric magnetic resonance imaging (MRI) is noninferior to multiparametric MRI for diagnosis of clinically significant...
4
15
24
The unstoppable @rjhowland is this year’s Bomalaski scholar! 💫Understanding the workforce needs in pediatric urology 💫
2
1
17
Prime Time 💯
Deion Sanders jokes he “depends on Depends” and “if you see a Port-a-Potty on the sideline, it’s real.” He also encourages everyone who is dealing with urinary struggles, and “let’s stop being ashamed of it”
0
1
8
NIH indirect funding cuts could derail scientific discovery for years to come. Our editorial in @UrolPractice explores what’s at stake for physician researchers: @wandering_gu @gpalapa2
https://t.co/kUjtsjaqvm
auajournals.org
2
8
25
Timely and accurate information about prostate cancer to share 👇🏻
Yesterday former President Joseph Biden’s office announced that his prostate cancer had spread to his bones. Our experts @wandering_gu and @tudor_borza answer questions about the current screening procedures and survival outlooks: https://t.co/ZYgqRv6amc.
0
0
4
bpMRI can improve comfort, time, and money for patients on active surveillance We’re starting to standardize this protocol for AS @UMichUrology @wandering_gu
0
0
2
Thank you @journotwit for highlighting our work about bpMRI! Awesome patient-perspective article: https://t.co/8983GiU8lb
1
1
3
1/ Has there been an improvement in surgical overtreatment of prostate cancer over the past 2 decades? Yes — and profoundly. In 2010, 1 in 3 prostatectomies 🔪 were for indolent disease. In 2024, it's 1 in 20. Read our work below, presented at #AUA2025 today. 🧵
Among two US prostate cancer registries, the proportion of patients undergoing prostatectomy for indolent cancer dropped over five-fold from 2010 to 2024. https://t.co/W7kcbtcUGe
3
10
27
Plenary talks this AM on mPCNL and stent omission by @sui_wilson and @peepeeDoctor @UMichUrology
#AUA25 🤩🤩
0
3
16
What happens in Vegas stays in Vegas…. Except for @MadisonKrischak and @h_gambrah crushing it on the big stage! #AUA25
0
1
11